278 related articles for article (PubMed ID: 26715443)
41. Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
Lee NH; Kang JM; Lee JW; Huh HJ; Lee NY; Yoo KH; Sung KW; Koo HH; Kim YJ
Pediatr Infect Dis J; 2020 Oct; 39(10):931-936. PubMed ID: 32453199
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
[TBL] [Abstract][Full Text] [Related]
43. [Microorganisms isolated from blood cultures and resistance profile in children with cancer and high-risk febrile neutropenia. Red PINDA, Chile, 2016-2021].
Valenzuela R; Riquelme C; de la Maza V; Álvarez AM; Contardo V; Ducasse K; Payá E; Claverie X; Venegas M; Santolaya ME
Andes Pediatr; 2024 Apr; 95(2):143-150. PubMed ID: 38801361
[TBL] [Abstract][Full Text] [Related]
44. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Cordonnier C; Herbrecht R; Pico JL; Gardembas M; Delmer A; Delain M; Moreau P; Ladeb S; Nalet V; Rollin C; Gres JJ
Clin Infect Dis; 1997 Jan; 24(1):41-51. PubMed ID: 8994754
[TBL] [Abstract][Full Text] [Related]
45. [Empirical cefepime monotherapy in febrile neutropenia].
Kliasova GA
Antibiot Khimioter; 2003; 48(7):33-7. PubMed ID: 14628577
[No Abstract] [Full Text] [Related]
46. Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Hui-Min Y; Yan-Ping W; Lin Liu Y; Shamsi BH; Bo H; Xu-Chun M
J Int Med Res; 2018 Jan; 46(1):225-233. PubMed ID: 28789605
[TBL] [Abstract][Full Text] [Related]
47. In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.
Tallis E; Rudensky B; Attias D; Raveh D; Schlesinger Y; Yinnon AM
Diagn Microbiol Infect Dis; 1999 Oct; 35(2):121-6. PubMed ID: 10579092
[TBL] [Abstract][Full Text] [Related]
48. [Bloodstream infections in children with cancer and high risk fever and neutropenia episodes in six hospitals of Santiago, Chile between 2004 and 2009].
Solís Y; Álvarez AM; Fuentes D; de la Barra D; Avilés CL; Becker A; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Aedo S; Santolaya ME
Rev Chilena Infectol; 2012 Apr; 29(2):156-62. PubMed ID: 22689029
[TBL] [Abstract][Full Text] [Related]
49. [Microorganisms isolated from blood cultures in children with cancer and high-risk febrile neutropenia from five hospitals in Santiago, Chile, 2012-2015].
Maldonado ME; Acuña M; Álvarez AM; Avilés CL; de la Maza V; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2018 Apr; 35(2):140-146. PubMed ID: 29912251
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic yield of blood cultures from antibiotic-naïve and antibiotically treated patients with haematological malignancies and high-risk neutropenia.
Hummel M; Warga C; Hof H; Hehlmann R; Buchheidt D
Scand J Infect Dis; 2009; 41(9):650-5. PubMed ID: 19562624
[TBL] [Abstract][Full Text] [Related]
51. Microbiological findings in febrile neutropenia.
Gaytán-Martínez J; Mateos-García E; Sánchez-Cortés E; González-Llaven J; Casanova-Cardiel LJ; Fuentes-Allen JL
Arch Med Res; 2000; 31(4):388-92. PubMed ID: 11068081
[TBL] [Abstract][Full Text] [Related]
52. [A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in patients with hematological malignancies].
Cai LJ; Wei XL; Wei YQ; Guo XT; Jiang XJ; Zhang Y; Yu GP; Dai M; Ye JY; Zhou HS; Xu D; Huang F; Fan ZP; Xu N; Shi PC; Xuan L; Feng R; Liu XL; Sun J; Liu QF
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):479-483. PubMed ID: 37550203
[No Abstract] [Full Text] [Related]
53. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
54. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia.
Schonardie AP; Beck E; Rigatto MH
Braz J Infect Dis; 2023; 27(2):102758. PubMed ID: 36809849
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Marini BL; Hough SM; Gregg KS; Abu-Seir H; Nagel JL
Support Care Cancer; 2015 Aug; 23(8):2287-95. PubMed ID: 25576429
[TBL] [Abstract][Full Text] [Related]
57. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
[TBL] [Abstract][Full Text] [Related]
59. A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.
Duncan C; Chisholm JC; Freeman S; Riley U; Sharland M; Pritchard-Jones K
Pediatr Blood Cancer; 2007 Oct; 49(5):678-81. PubMed ID: 17066460
[TBL] [Abstract][Full Text] [Related]
60. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.
Bakhshi S; Padmanjali KS; Arya LS
Pediatr Hematol Oncol; 2008 Jun; 25(5):385-92. PubMed ID: 18569840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
